Why Special Transport Systems Are Needed
Not all molecules can easily cross the lipid bilayer of the cell membrane via simple passive diffusion. To transport specific groups of substances, the cell utilizes specialized carrier protein molecules (transportatores) that span the membrane.
These systems are required by:
- Hydrophilic compounds, as they are physically insoluble in the lipids of the cell wall.
- Macromolecular compounds, whose size significantly exceeds the diameter of membrane pores.
Physiologically, these transport proteins perform two overarching tasks. First, they ensure the influx of vital nutrients into the cell, such as amino acids, vitamins, or sugars. Second, they guarantee efflux — the removal of endogenous metabolic waste products, toxins, and various xenobiotics.
Molecular Mechanism of Active Transport
The key element of this process is the membrane carrier protein (proteinum transportans). The mechanism of its operation follows a strict sequence of steps:
- On one side of the membrane, the transported substance is recognized by and binds to the active site of the carrier protein.
- Hydrolysis of a high-energy compound occurs — the breakdown of an ATP (Adenosinum triphosphatum) molecule into ADP (Adenosinum diphosphatum) and inorganic phosphate. The energy from breaking the phosphate bond is transferred to the transport system.
- Driven by this energy, the protein alters its spatial structure (undergoing a conformational change).
- The substance is carried across the membrane barrier.
- The binding affinity between the molecule and the carrier drops, after which the substrate is released on the opposite side of the membrane into the cytoplasm or the interstitial space.
Classification Based on Energy Source
Because active transport always operates against a concentration gradient, it continually requires energy. Depending on the exact source of this energy, two types of transport are distinguished.
Primary Active Transport Here, the system operates directly from "cellular batteries." Energy for substrate transfer is released immediately during the hydrolysis of an ATP molecule.
Secondary Active Transport This type of transport operates via coupling. Energy is derived from the transport of another ion (most commonly a sodium ion, $Na^+$), which moves down its electrochemical gradient. Importantly, this sodium gradient itself is previously established by the action of the $Na^+, K^+$-ATPase. Meanwhile, the transported substance is "carried" against its own gradient.
Secondary transport is further subdivided based on the direction of particle movement:
- Symport (cotransport): The sodium ion and the target substance move strictly in the same direction.
- Antiport: The sodium ion and the substance move in opposite, counter directions.
Facilitated Diffusion (Diffusio facilitata)
Facilitated diffusion is a related process often discussed alongside active transport because it also requires a carrier protein. A classic example of this mechanism is glucose transport into cells.
Main Difference: The process proceeds down the concentration gradient (from higher to lower concentration), and therefore requires absolutely no expenditure of metabolic energy.
Similarities with Active Transport:
- The mechanism of interaction with the membrane protein is identical (binding, conformational change, release).
- It exhibits strict specificity for the transported molecules.
- It is characterized by saturability (velocity is limited by the number of available carriers).
Pharmacological Significance: How Drugs Penetrate Tissues
Normally, transport systems are intended exclusively for "native" endogenous substances—sugars, iron, purine bases, or amino acids. A drug molecule (medicamentum) cannot simply hijack a carrier protein at will.
The primary prerequisite for drug transport is the presence of a chemical resemblance between the drug molecule and the body's natural endogenous substrates. The drug must literally mimic a natural substance so that the transporter protein mistakes it for a native molecule.
A striking clinical example of this molecular deception is the antiparkinsonian drug Levodopa (dihydroxyphenylalanine). To cross the tight blood-brain barrier (BBB), levodopa mimics a natural amino acid. As a result, it is successfully transported across the barrier via a specific aromatic amino acid transporter protein.